DVAX

Dynavax Technologies Corporation

Price

return (12m)

0.00%

p/e

-41.79

p/bv

3.40

DIVIDEND YIELD

0.00%

DVAX price

Dynavax Technologies

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment DVAX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals DVAX

Valuation

P/E

-41.79

Sector -4.25

Industry -4.25

P/BV

3.40

Sector 2.06

Industry 2.06

P/Revenue (PSR)

5.49

Sector -4.32

Industry -4.32

EV/EBITDA

43.48

Sector -222.95

Industry -222.95

EV/EBIT

46.53

Sector -662.78

Industry -662.78

P/EBITDA

-66.21

Sector -4.42

Industry -4.42

P/EBIT

-53.99

Sector -4.65

Industry -4.65

P/Total Assets

1.92

Sector 1.48

Industry 1.48

P/Net Current Assets

4.51

Sector -11.89

Industry -11.89

P/Working Capital

2.56

Sector -12.40

Industry -12.40

EPS

-0.37

Sector -2.19

Industry -2.19

BVPS

4.57

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

83.17%

Sector 36.35%

Industry 36.35%

EBITDA Margin

33.61%

Sector -16,780.87%

Industry -16,780.87%

EBIT Margin

31.41%

Sector -4,293,432.86%

Industry -4,293,432.86%

Operating Margin

6.48%

Sector -38.73%

Industry -38.73%

Net Profit Margins

-13.13%

Sector -39.98%

Industry -39.98%

Asset Turnover

0.10

Sector 0.03

Industry 0.03

Profitability

ROE

-8.13%

Sector -66.50%

Industry -66.50%

ROA

-4.59%

Sector -65.95%

Industry -65.95%

ROIC

34.54%

Sector -2,064.28%

Industry -2,064.28%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

7.62

Sector 2.88

Industry 2.88

Net Debt / EBITDA

-13.39

Sector -14.67

Industry -14.67

Net Debt / EBIT

-14.32

Sector -8.47

Industry -8.47

Net Debt / Equity

-0.80

Sector -1.08

Industry -1.08

Gross Debt / Equity

0.41

Sector -0.75

Industry -0.75

Equity/Assets

0.56

Sector 0.41

Industry 0.41

Liabilities/Assets

0.44

Sector 0.40

Industry 0.40

Growth

5Y Revenue CAGR

-5.54%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals DVAX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
DVAX Dynavax Technologies Corporation	$0.00	-100.00%	0.00%	-41.79	3.40	-8.13%	-13.13%
JNJ Johnson & Johnson	$260.56	53.93%	2.05%	29.23	7.24	24.76%	21.48%
PFE Pfizer Inc.	$26.78	15.88%	6.61%	34.22	1.73	5.07%	6.80%
ABBV AbbVie Inc.	$249.75	29.02%	2.72%	69.54	-74.01	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.08	-4.01%	4.00%	11.36	6.03	53.11%	35.32%
MRK Merck & Co. Inc.	$134.41	68.99%	2.49%	105.02	7.94	7.56%	4.77%
AZN AstraZeneca PLC	$155.78	1.63%	2.01%	23.71	4.92	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$63.93	39.94%	3.91%	14.14	5.88	41.59%	18.87%
ZTS Zoetis Inc.	$74.44	-50.06%	2.81%	11.73	9.74	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$802.27	42.53%	0.47%	18.55	2.53	13.65%	27.86%
AMGN Amgen Inc.	$412.19	47.69%	2.43%	24.89	18.62	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$98.35	51.01%	0.00%	28.46	82.01	288.14%	24.86%
MCK McKesson Corporation	$866.22	31.29%	0.37%	22.83	-80.58	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$507.39	28.15%	0.00%	28.28	6.15	21.76%	35.00%
CAH Cardinal Health Inc.	$233.04	58.99%	0.86%	36.08	-21.00	-58.20%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$38.08	3.85%	0.00%	12.41	2.25	18.14%	18.89%
BIIB Biogen Inc.	$208.88	54.51%	0.00%	36.48	1.62	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

DVAX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Dynavax Technologies

Dynavax Technologies Corporation

Average Investor10 user rating

4.0 (2 people)

United States

30 years

Founded: 1996

2004

Time since IPO - 22 years

245

Employees

Dynavax Technologies Corporation (United States) is listed on the Nasdaq and has a market capitalization of $1.81 billion, with shareholders equity totaling $534.14 million.

The company employs approximately 245 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Dynavax Technologies Corporation reported $330.51 million in revenue, generating net income of $-43.40 million.

Key financial metrics include a P/E ratio of -41.79, a price-to-book (P/B) ratio of 3.40, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker DVAX.

Market cap

$1.81 billion

Net worth

$534.14 million

$534,140,000.00

Assets

$946.51 million

$946,510,000.00

Total Shares Outstanding

117.00 million

117,000,000

Average Daily Trading Volume

$3.32 million

$3,320,644.92

Sector

Health Care

Industry

Biotechnology

DVAX

DVAX revenue and profits

Financial Results DVAX

DRAG THE FRAME TO SEE MORE DATA

DVAX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$866.22 29,36% (12M)

P/E

22.83

0.37%

ROE

-352.96%

P/BV

-80.58

CAH - Cardinal Health

$233.04 57,40% (12M)

P/E

36.08

0.86%

ROE

-58.20%

P/BV

-21.00

JNJ - Johnson & Johnson

$260.56 52,00% (12M)

P/E

29.23

2.05%

ROE

24.76%

P/BV

7.24

ABBV - AbbVie

$249.75 24,69% (12M)

P/E

69.54

2.72%

ROE

-106.44%

P/BV

-74.01

MRK - Merck & Co.

$134.41 65,98% (12M)

P/E

105.02

2.49%

ROE

7.56%

P/BV

7.94

AZN - AstraZeneca

$155.78 0,80% (12M)

P/E

23.71

2.01%

ROE

20.74%

P/BV

4.92

PFE - Pfizer

$26.78 15,97% (12M)

P/E

34.22

6.61%

ROE

5.07%

P/BV

1.73

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$866.22 29,36% (12 M)

P/L

22.83

0.37%

ROE

-352.96%

P/VP

-80.58

CAH - Cardinal Health

$233.04 57,40% (12 M)

P/L

36.08

0.86%

ROE

-58.20%

P/VP

-21.00

JNJ - Johnson & Johnson

$260.56 52,00% (12 M)

P/L

29.23

2.05%

ROE

24.76%

P/VP

7.24

ABBV - AbbVie

$249.75 24,69% (12 M)

P/L

69.54

2.72%

ROE

-106.44%

P/VP

-74.01

MRK - Merck & Co.

$134.41 65,98% (12 M)

P/L

105.02

2.49%

ROE

7.56%

P/VP

7.94

AZN - AstraZeneca

$155.78 0,80% (12 M)

P/L

23.71

2.01%

ROE

20.74%

P/VP

4.92

PFE - Pfizer

$26.78 15,97% (12 M)

P/L

34.22

6.61%

ROE

5.07%

P/VP

1.73

Frequently Asked Questions

What is the price of Dynavax Technologies (DVAX) today?

A cotação de Dynavax Technologies (DVAX) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Dynavax Technologies (DVAX) iniciou o ano negociando na casa dos US$ 15.38 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Dynavax Technologies (DVAX) e dados de ações do Ibovespa e mercados internacionais.

Quando Dynavax Technologies (DVAX) paga dividendos?

Dynavax Technologies (DVAX) não distribuiu dividendos no último ano.

Is Dynavax Technologies (DVAX) a good investment?

Atualmente, Dynavax Technologies (DVAX) está cotada a US$ 0.00, com um P/L de -41.79, representando um desvio de -6,507% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Dynavax Technologies (DVAX) stock?

Investir em ações de Dynavax Technologies (DVAX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Dynavax Technologies (DVAX) yield today?

A rentabilidade de Dynavax Technologies (DVAX) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Dynavax Technologies (DVAX) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

DVAX

Dynavax Technologies Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment DVAX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING DVAX WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Dynavax Technologies

Dynavax Technologies Corporation

United States

30 years

2004

245

PROFIT X PRICE DVAX

Financial Results DVAX

DVAX cash flow

Asset, Revenue and Profit Growth - DVAX

DVAX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions